Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
Looking Back at a Defunct ID Meeting — and Ahead to a Thriving One • April 12, 2025
Back in prehistoric times, many ID doctors and microbiologists would gather each fall at a meeting to review the latest antimicrobial clinical trials and promising “bug-drug” studies of novel compounds in development. The meeting was called the Interscience Conference on Antimicrobial Agents and Chemotherapy, abbreviated ICAAC. There were a bunch of problems with ICAAC. First, […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.Statements and opinions expressed in these blogs reflect the views of the author(s) and not necessarily the official policy of NEJM Journal Watch, NEJM Group, or the Massachusetts Medical Society, unless so stated.
NEJM Journal Watch — Recent Infectious Diseases Articles- Incidence of Invasive Group A Streptococcus Infection Is Rising
- Observations from ID and Beyond: Gepotidacin — New Antibiotic or Rare Tropical Bird?
- Developing a Blood Test to Differentiate Between Active and Latent TB
- Optimizing Staffing for Outpatient Parenteral Antimicrobial Therapy
- Comparing Antipseudomonal Antibiotics for Managing Pseudomonas aeruginosa Bacteremia in the ICU
- NEJM Journal Watch — Recent General Medicine Articles